ID   NRP1_RAT                Reviewed;         922 AA.
AC   Q9QWJ9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 186.
DE   RecName: Full=Neuropilin-1;
DE   AltName: Full=Vascular endothelial cell growth factor 165 receptor;
DE   AltName: CD_antigen=CD304;
DE   Flags: Precursor;
GN   Name=Nrp1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=9288754; DOI=10.1016/s0092-8674(00)80535-8;
RA   Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.-T., Giger R.J.,
RA   Ginty D.D.;
RT   "Neuropilin is a semaphorin III receptor.";
RL   Cell 90:753-762(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY, AND INDUCTION BY INJURY.
RX   PubMed=28270793; DOI=10.3389/fneur.2017.00049;
RA   Lindholm T., Risling M., Carlstedt T., Hammarberg H., Wallquist W.,
RA   Cullheim S., Skoeld M.K.;
RT   "Expression of Semaphorins, Neuropilins, VEGF, and Tenascins in Rat and
RT   Human Primary Sensory Neurons after a Dorsal Root Injury.";
RL   Front. Neurol. 8:49-49(2017).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 273-586 IN COMPLEX WITH VEGF
RP   FRAGMENT, HEPARIN-BINDING, AND DISULFIDE BONDS.
RX   PubMed=17405859; DOI=10.1073/pnas.0700043104;
RA   Vander Kooi C.W., Jusino M.A., Perman B., Neau D.B., Bellamy H.D.,
RA   Leahy D.J.;
RT   "Structural basis for ligand and heparin binding to neuropilin B domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:6152-6157(2007).
CC   -!- FUNCTION: Cell-surface receptor involved in the development of the
CC       cardiovascular system, in angiogenesis, in the formation of certain
CC       neuronal circuits and in organogenesis outside the nervous system.
CC       Mediates the chemorepulsant activity of semaphorins. Recognizes a C-end
CC       rule (CendR) motif R/KXXR/K on its ligands which causes cellular
CC       internalization and vascular leakage. It binds to semaphorin 3A, the
CC       PLGF-2 isoform of PGF, the VEGF165 isoform of VEGFA and VEGFB (By
CC       similarity). Coexpression with KDR results in increased VEGF165 binding
CC       to KDR as well as increased chemotaxis. Regulates VEGF-induced
CC       angiogenesis. Binding to VEGFA initiates a signaling pathway needed for
CC       motor neuron axon guidance and cell body migration, including for the
CC       caudal migration of facial motor neurons from rhombomere 4 to
CC       rhombomere 6 during embryonic development (By similarity). Regulates
CC       mitochondrial iron transport via interaction with ABCB8/MITOSUR (By
CC       similarity). {ECO:0000250|UniProtKB:O14786,
CC       ECO:0000250|UniProtKB:P97333}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with NRP2. Binds PLXNB1 (By
CC       similarity). Interacts with FER. Interacts with VEGFA (By similarity).
CC       Interacts with ABCB8/MITOSUR in mitochondria (By similarity).
CC       {ECO:0000250|UniProtKB:O14786, ECO:0000250|UniProtKB:P97333}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:O14786}; Single-pass type I membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:O14786}; Single-
CC       pass type I membrane protein {ECO:0000255}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O14786}.
CC   -!- TISSUE SPECIFICITY: Found in the embryonic nervous system
CC       (PubMed:9288754). Expressed in dorsal root ganglia (PubMed:28270793).
CC       {ECO:0000269|PubMed:28270793, ECO:0000269|PubMed:9288754}.
CC   -!- INDUCTION: Increased in dorsal root ganglia in response to injury
CC       caused by dorsal rhizotomy (PubMed:28270793). Increased in dorsal root
CC       ganglia in response to both sciatic nerve crush and transection injury
CC       (PubMed:28270793). {ECO:0000269|PubMed:28270793}.
CC   -!- DOMAIN: The tandem CUB domains mediate binding to semaphorin, while the
CC       tandem F5/8 domains are responsible for heparin and VEGF binding. F5/8
CC       domains mediate the recognition and binding to R/KXXR/K CendR motifs.
CC       {ECO:0000250|UniProtKB:O14786}.
CC   -!- SIMILARITY: Belongs to the neuropilin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF016296; AAC53337.1; -; mRNA.
DR   EMBL; BC085689; AAH85689.1; -; mRNA.
DR   RefSeq; NP_659566.1; NM_145098.2.
DR   RefSeq; XP_006255887.1; XM_006255825.3.
DR   PDB; 2ORX; X-ray; 2.40 A; A=273-586.
DR   PDB; 2ORZ; X-ray; 2.15 A; A=273-586.
DR   PDBsum; 2ORX; -.
DR   PDBsum; 2ORZ; -.
DR   AlphaFoldDB; Q9QWJ9; -.
DR   SMR; Q9QWJ9; -.
DR   BioGRID; 251596; 4.
DR   DIP; DIP-44935N; -.
DR   IntAct; Q9QWJ9; 2.
DR   STRING; 10116.ENSRNOP00000075034; -.
DR   BindingDB; Q9QWJ9; -.
DR   ChEMBL; CHEMBL3309098; -.
DR   GlyCosmos; Q9QWJ9; 6 sites, No reported glycans.
DR   GlyGen; Q9QWJ9; 7 sites.
DR   iPTMnet; Q9QWJ9; -.
DR   PhosphoSitePlus; Q9QWJ9; -.
DR   SwissPalm; Q9QWJ9; -.
DR   PaxDb; 10116-ENSRNOP00000014492; -.
DR   Ensembl; ENSRNOT00000014492.6; ENSRNOP00000014492.3; ENSRNOG00000010744.6.
DR   Ensembl; ENSRNOT00055008628; ENSRNOP00055006532; ENSRNOG00055005353.
DR   Ensembl; ENSRNOT00060008991; ENSRNOP00060006780; ENSRNOG00060005340.
DR   Ensembl; ENSRNOT00065031030; ENSRNOP00065024713; ENSRNOG00065018438.
DR   GeneID; 246331; -.
DR   KEGG; rno:246331; -.
DR   UCSC; RGD:621588; rat.
DR   AGR; RGD:621588; -.
DR   CTD; 8829; -.
DR   RGD; 621588; Nrp1.
DR   eggNOG; ENOG502QUEH; Eukaryota.
DR   GeneTree; ENSGT00940000157169; -.
DR   HOGENOM; CLU_015228_6_1_1; -.
DR   InParanoid; Q9QWJ9; -.
DR   OMA; QEDCTKP; -.
DR   OrthoDB; 5293253at2759; -.
DR   PhylomeDB; Q9QWJ9; -.
DR   TreeFam; TF316506; -.
DR   Reactome; R-RNO-194306; Neurophilin interactions with VEGF and VEGFR.
DR   Reactome; R-RNO-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-RNO-399955; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion.
DR   Reactome; R-RNO-399956; CRMPs in Sema3A signaling.
DR   Reactome; R-RNO-445144; Signal transduction by L1.
DR   EvolutionaryTrace; Q9QWJ9; -.
DR   PRO; PR:Q9QWJ9; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000010744; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005883; C:neurofilament; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0097443; C:sorting endosome; ISO:RGD.
DR   GO; GO:0019838; F:growth factor binding; ISO:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0017154; F:semaphorin receptor activity; IMP:RGD.
DR   GO; GO:0038085; F:vascular endothelial growth factor binding; ISO:RGD.
DR   GO; GO:0005021; F:vascular endothelial growth factor receptor activity; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0060978; P:angiogenesis involved in coronary vascular morphogenesis; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0048675; P:axon extension; ISO:RGD.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; ISO:RGD.
DR   GO; GO:0007411; P:axon guidance; ISO:RGD.
DR   GO; GO:0007413; P:axonal fasciculation; ISO:RGD.
DR   GO; GO:0060385; P:axonogenesis involved in innervation; ISO:RGD.
DR   GO; GO:0150020; P:basal dendrite arborization; ISO:RGD.
DR   GO; GO:0150018; P:basal dendrite development; ISO:RGD.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0021785; P:branchiomotor neuron axon guidance; ISO:RGD.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; ISO:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISO:RGD.
DR   GO; GO:0071679; P:commissural neuron axon guidance; ISO:RGD.
DR   GO; GO:0060982; P:coronary artery morphogenesis; ISO:RGD.
DR   GO; GO:0016358; P:dendrite development; ISO:RGD.
DR   GO; GO:0060666; P:dichotomous subdivision of terminal units involved in salivary gland branching; ISO:RGD.
DR   GO; GO:1904835; P:dorsal root ganglion morphogenesis; ISO:RGD.
DR   GO; GO:0035767; P:endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0021612; P:facial nerve structural organization; ISO:RGD.
DR   GO; GO:1903375; P:facioacoustic ganglion development; ISO:RGD.
DR   GO; GO:0021828; P:gonadotrophin-releasing hormone neuronal migration to the hypothalamus; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0048012; P:hepatocyte growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISO:RGD.
DR   GO; GO:0097475; P:motor neuron migration; ISS:UniProtKB.
DR   GO; GO:0030517; P:negative regulation of axon extension; ISO:RGD.
DR   GO; GO:0048843; P:negative regulation of axon extension involved in axon guidance; IMP:RGD.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; NAS:RGD.
DR   GO; GO:0001755; P:neural crest cell migration; IBA:GO_Central.
DR   GO; GO:1901166; P:neural crest cell migration involved in autonomic nervous system development; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0038189; P:neuropilin signaling pathway; ISO:RGD.
DR   GO; GO:1905040; P:otic placode development; ISO:RGD.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISO:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050918; P:positive chemotaxis; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISO:RGD.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; ISO:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; ISO:RGD.
DR   GO; GO:0010641; P:positive regulation of platelet-derived growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0071673; P:positive regulation of smooth muscle cell chemotaxis; IMP:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISO:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:1904754; P:positive regulation of vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0099173; P:postsynapse organization; ISO:RGD.
DR   GO; GO:1902946; P:protein localization to early endosome; ISO:RGD.
DR   GO; GO:0048841; P:regulation of axon extension involved in axon guidance; ISO:RGD.
DR   GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; ISO:RGD.
DR   GO; GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0061441; P:renal artery morphogenesis; ISO:RGD.
DR   GO; GO:0009611; P:response to wounding; IBA:GO_Central.
DR   GO; GO:0061298; P:retina vasculature development in camera-type eye; ISO:RGD.
DR   GO; GO:0061299; P:retina vasculature morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISO:RGD.
DR   GO; GO:0071526; P:semaphorin-plexin signaling pathway; ISO:RGD.
DR   GO; GO:0097374; P:sensory neuron axon guidance; ISO:RGD.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISO:RGD.
DR   GO; GO:0061549; P:sympathetic ganglion development; ISO:RGD.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISO:RGD.
DR   GO; GO:0097490; P:sympathetic neuron projection extension; ISO:RGD.
DR   GO; GO:0097491; P:sympathetic neuron projection guidance; ISO:RGD.
DR   GO; GO:0061551; P:trigeminal ganglion development; ISO:RGD.
DR   GO; GO:0021636; P:trigeminal nerve morphogenesis; ISO:RGD.
DR   GO; GO:0021637; P:trigeminal nerve structural organization; ISO:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; IBA:GO_Central.
DR   GO; GO:0038190; P:VEGF-activated neuropilin signaling pathway; ISO:RGD.
DR   GO; GO:0036486; P:ventral trunk neural crest cell migration; ISO:RGD.
DR   GO; GO:0021649; P:vestibulocochlear nerve structural organization; ISO:RGD.
DR   GO; GO:0042060; P:wound healing; IMP:RGD.
DR   CDD; cd00041; CUB; 2.
DR   CDD; cd00057; FA58C; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.120.200; -; 1.
DR   Gene3D; 2.60.120.260; Galactose-binding domain-like; 2.
DR   Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR014648; Neuropilin.
DR   InterPro; IPR022579; Neuropilin_C.
DR   InterPro; IPR050633; Neuropilin_MCO_CoagFactor.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   PANTHER; PTHR46806; F5/8 TYPE C DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR46806:SF4; NEUROPILIN-1; 1.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF11980; DUF3481; 1.
DR   Pfam; PF00754; F5_F8_type_C; 2.
DR   Pfam; PF00629; MAM; 1.
DR   PIRSF; PIRSF036960; Neuropilin; 1.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00231; FA58C; 2.
DR   SMART; SM00137; MAM; 1.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1.
DR   SUPFAM; SSF49785; Galactose-binding domain-like; 2.
DR   SUPFAM; SSF49854; Spermadhesin, CUB domain; 2.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS01285; FA58C_1; 2.
DR   PROSITE; PS01286; FA58C_2; 2.
DR   PROSITE; PS50022; FA58C_3; 2.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Angiogenesis; Calcium; Cell membrane; Cytoplasm;
KW   Developmental protein; Differentiation; Disulfide bond; Glycoprotein;
KW   Heparan sulfate; Heparin-binding; Membrane; Metal-binding; Mitochondrion;
KW   Neurogenesis; Phosphoprotein; Proteoglycan; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..922
FT                   /note="Neuropilin-1"
FT                   /id="PRO_0000021861"
FT   TOPO_DOM        22..855
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        856..880
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        881..922
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..141
FT                   /note="CUB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          147..265
FT                   /note="CUB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DOMAIN          275..424
FT                   /note="F5/8 type C 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          431..583
FT                   /note="F5/8 type C 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          645..811
FT                   /note="MAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00128"
FT   BINDING         195
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   BINDING         209
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   BINDING         250
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97333"
FT   CARBOHYD        150
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        522
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        612
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine;
FT                   alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   CARBOHYD        612
FT                   /note="O-linked (Xyl...) (heparan sulfate) serine;
FT                   alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   CARBOHYD        829
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   CARBOHYD        841
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        27..54
FT                   /evidence="ECO:0000305|PubMed:17405859"
FT   DISULFID        82..104
FT                   /evidence="ECO:0000305|PubMed:17405859"
FT   DISULFID        147..173
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   DISULFID        206..228
FT                   /evidence="ECO:0000250|UniProtKB:O14786"
FT   DISULFID        275..424
FT                   /evidence="ECO:0000269|PubMed:17405859"
FT   DISULFID        431..583
FT                   /evidence="ECO:0000269|PubMed:17405859"
FT   TURN            281..283
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   HELIX           288..290
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          291..294
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   HELIX           299..301
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   HELIX           303..305
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          326..342
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   TURN            347..349
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          352..368
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          385..389
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          391..414
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          417..424
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   HELIX           426..428
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          429..431
FT                   /evidence="ECO:0007829|PDB:2ORX"
FT   STRAND          432..434
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   TURN            437..439
FT                   /evidence="ECO:0007829|PDB:2ORX"
FT   HELIX           442..444
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          445..449
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   HELIX           459..462
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   TURN            464..466
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          467..469
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          471..473
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          485..501
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          503..505
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          508..510
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          512..525
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          534..537
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          544..547
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          550..570
FT                   /evidence="ECO:0007829|PDB:2ORZ"
FT   STRAND          573..583
FT                   /evidence="ECO:0007829|PDB:2ORZ"
SQ   SEQUENCE   922 AA;  103082 MW;  CC6F82AD098B0F2E CRC64;
     MERGLPLLCA TLALALALAG AFRSDKCGGT IKIENPGYLT SPGYPHSYHP SEKCEWLIQA
     PEPYQRIMIN FNPHFDLEDR DCKYDYVEVI DGENEGGRLW GKFCGKIAPS PVVSSGPFLF
     IKFVSDYETH GAGFSIRYEI FKRGPECSQN YTAPTGVIKS PGFPEKYPNS LECTYIIFAP
     KMSEIILEFE SFDLEQDSNP PGGVFCRYDR LEIWDGFPEV GPHIGRYCGQ KTPGRIRSSS
     GILSMVFYTD SAIAKEGFSA NYSVLQSSIS EDFKCMEALG MESGEIHSDQ ITASSQYGTN
     WSVERSRLNY PENGWTPGED SYREWIQVDL GLLRFVTAVG TQGAISKETK KKYYVKTYRV
     DISSNGEDWI TLKEGNKAII FQGNTNPTDV VFGVFPKPLI TRFVRIKPAS WETGISMRFE
     VYGCKITDYP CSGMLGMVSG LISDSQITAS NQGDRNWMPE NIRLVTSRTG WALPPSPHPY
     INEWLQVDLG DEKIVRGVII QGGKHRENKV FMRKFKIAYS NNGSDWKMIM DDSKRKAKSF
     EGNNNYDTPE LRAFTPLSTR FIRIYPERAT HSGLGLRMEL LGCEVEVPTA GPTTPNGNPV
     DECDDDQANC HSGTGDDFQL TGGTTVLATE KPTIIDSTIQ SEFPTYGFNC EFGWGSHKTF
     CHWEHDSHAQ LRWRVLTSKT GPIQDHTGDG NFIYSQADEN QKGKVARLVS PVVYSQSSAH
     CMTFWYHMSG SHVGTLRVKL HYQKPEEYDQ LVWMVVGHQG DHWKEGRVLL HKSLKLYQVI
     FEGEIGKGNL GGIAVDDISI NNHIPQEDCA KPTDLDKKNT EIKIDETGST PGYEEGKGDK
     NISRKPGNVL KTLDPILITI IAMSALGVLL GAVCGVVLYC ACWHNGMSER NLSALENYNF
     ELVDGVKLKK DKLNPQSNYS EA
//
